Tenaya Therapeutics, Inc.TNYANASDAQ

Revenue (LTM)

Net Income (LTM)

$-91M

+18.5% YoY

Free Cash Flow

$-69M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	-4	-9↓116.5%	-9↑0.3%	-8↑2.5%	-8↑0.4%
Operating Income	-73	-126↓72.5%	-131↓4.4%	-116↑11.6%	-93↑19.5%
Net Income	-73	-124↓70.1%	-124↓0.3%	-111↑10.4%	-91↑18.5%
EBITDA	-69	-115↓67.3%	-115↓0.4%	-103↑11.0%	-85↑17.3%
EPS Diluted	-1.69	-2.76↓63.3%	-1.68↑39.1%	-1.31↑22.0%	-0.59↑55.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	38	95↑149.9%	46↓52.1%	4↓90.5%	101↑2225.9%
Total Current Assets	255	194↓24.1%	112↓42.4%	67↓39.6%	106↑56.7%
Total Assets	317	279↓11.9%	171↓38.9%	120↓29.7%	147↑22.5%
Total Current Liabilities	22	24↑11.4%	23↓6.2%	16↓29.7%	15↓3.4%
Total Liabilities	38	36↓6.7%	31↓12.6%	27↓12.9%	24↓12.7%
Total Equity	279	243↓12.6%	139↓42.7%	93↓33.4%	123↑32.8%
Total Debt	16	15↓3.8%	12↓17.7%	14↑9.5%	11↓20.4%
Net Debt	-22	-80↓257.5%	-33↑58.5%	9↑127.9%	-90↓1066.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-61	-104↓71.7%	-102↑2.3%	-91↑11.3%	-68↑24.6%
Capital Expenditure	-25	-21↑17.9%	-1↑94.0%	-1↑17.3%	-1↑39.7%
Free Cash Flow	-86	-125↓45.5%	-103↑17.4%	-92↑11.4%	-69↑24.7%
Stock-Based Comp	3	11↑288.7%	15↑33.5%	17↑7.8%	13↓20.9%
Net Change in Cash	-90	57↑163.0%	-49↓186.5%	-42↑15.6%	96↑331.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance